http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101014074-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7092
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 2002-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101014074-B1
titleOfInvention Percutaneous treatment system containing tulobuterol hydrochloride for transdermal administration of bronchodilator tulobuterol
abstract A transdermal treatment system comprising a vapor impermeable support layer as well as a totally removable protective layer, a matrix layer comprising the active substance tulobuterol and containing at least one active substance, wherein the matrix is prepared on the basis of a polyacrylate pressure sensitive adhesive. It is characterized in that it contains a tulobuterol in the form of a tulobuterol hydrochloride as an active substance.n n n Transdermal treatment system, tulobuterol.
priorityDate 1999-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407295578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454190589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452479221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449637609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23669631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23674961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45357807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449402145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10290730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448352729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11005

Total number of triples: 56.